BioLife's CEO Mike Rice will be presenting at the 4th Annual European Advanced Therapies Day on November 3rd at 30 Euston Square, London, England.
This one-day, invitation-only meeting provides institutional, corporate and private investors with unique insight into the investment hypothesis for advanced therapies-based treatments and tools. The program includes talks by large pharmaceutical and enabling tools and services executives currently leading investment and partnerships in the space. Clinical and commercial experts will be on-hand to address specific questions regarding the outlook for these products, as well as offer insight into how these technologies could impact the standard of care in key therapeutic areas. Attendees will also hear from life science investment experts and analysts covering the sector, as well as presentations by leading European and international advanced therapies companies.
Additional information about the event can be found at: http://eu.arminvestorday.com.